SCHEMBL30176382

SCHEMBL30176382

Fc1ccc(Nc2ccccc2C#CC2CCOCC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.35
MAPK14 Q16539 3/20 0.35
MAPK10 P53779 3/20 0.35
MAPK8 P45983 2/20 0.35
HTR2A P28223 1/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 2/20 0.34
CTSL P07711 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 2/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30234442 0.76 CTSV (0.36) LMNACTSLALDH1A1SMN1; SMN2
SCHEMBL23883949 0.76 CTSV (0.36) LMNACTSLALDH1A1SMN1; SMN2
SCHEMBL21900949 0.75 HDAC1 (0.34) GRM5MAPK14MAPK10MAPK8
SCHEMBL21900948 0.74 CDC7 (0.41) GRM5HTR2ARAB9ANPC1
SCHEMBL29536029 0.74 CDC7 (0.41) GRM5HTR2ARAB9ANPC1
SCHEMBL22688397 0.73 LRRK2 (0.38) GRM5MAPK14MAPK10MAPK8HTR2A
SCHEMBL30234541 0.72 CASP3 (0.35) GRM5MAPK14MAPK10MAPK8MAPT
SCHEMBL23883846 0.72 CASP3 (0.35) GRM5MAPK14MAPK10MAPK8MAPT
SCHEMBL23884018 0.72 CTSV (0.37) GRM5HTR2ACTSLALDH1A1
SCHEMBL30235230 0.72 CTSV (0.37) GRM5HTR2ACTSLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed